IMJ November (Vol 55, Iss 11) is now online bit.ly/47HoPbI @theracp.bsky.social @marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social

IMJ September 2025 #OpenAccess Editor's Choice (Clinical Perspective): Medicinal cannabis: is current use clinically justified? bit.ly/3K3qDDO @theracp.bsky.social

IMJ September 2025 #FreeAccess Review: Replacement therapy in congenital adrenal hyperplasia bit.ly/3HF9KPi @theracp.bsky.social

IMJ September 2025 #FreeAccess Original Article: In-hospital cardiac arrest bit.ly/4p5P8QZ @theracp.bsky.social

IMJ September 2025 #FreeAccess Original Article: Is incidence and burden of cancer increasing among young individuals? bit.ly/4p88bdh @theracp.bsky.social

IMJ September 2025 #OpenAccess Original Article: Automatic screening for viral hepatitis in an Emergency Department bit.ly/46h53EB @theracp.bsky.social

IMJ September 2025 #FreeAccess Original Article: Lung transplantation for interstitial lung diseases bit.ly/3JELX2B @theracp.bsky.social

IMJ October 2025 #OpenAccess Editor's Choice (Clinical Perspective): Hyperhidrosis: don’t sweat it bit.ly/42uVLmg @theracp.bsky.social

IMJ October 2025 #FreeAccess Editorial: A, B, C or D? Goals of Care: a need for a national structural framework. bit.ly/46JpvOI @theracp.bsky.social

A bumper issue of @the-imj.bsky.social Congratulations.

IMJ September (Volume 55, Issue 9) is now online bit.ly/45ZaKpj @theracp.bsky.social @marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social

IMJ August 2025 #FreeAccess Editor's Choice (Original Article): Glomerular disease registry and Biobank bit.ly/3ULSydE @theracp.bsky.social @marrow.bsky.social @sunilbadve.bsky.social

IMJ August 2025 #OpenAccess Original Article: Hyperuricaemia in Type 1 Gaucher disease bit.ly/3Hl6zMi @theracp.bsky.social @marrow.bsky.social

IMJ August (Vol 55, Iss 8) is now online bit.ly/3J5Ndvm @theracp.bsky.social @marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social

IMJ July 2025 #OpenAccess Editor's choice (review): Generative artificial intelligence in healthcare bit.ly/4loWVXS @theracp.bsky.social GenAI in clinical healthcare could be transformative. However, numerous challenges exist including technological, regulatory, workforce adaption, and trust.

IMJ July 2025 #FreeAccess Editorial: Are Australians Living with Dementia Ready for New Therapies? bit.ly/4eEYE8M @theracp.bsky.social

IMJ July 2025 #OpenAccess Original Article: Alzheimer disease: rollout of amyloid-targeting therapies bit.ly/3Il89Oq @theracp.bsky.social

IMJ July 2025 #FreeAccess Clinical Perspective: Management of pulmonary fibrosis bit.ly/3IkW7EO @theracp.bsky.social New research is expanding pulmonary fibrosis treatment beyond IPF to other fibrotic ILDs, integrating targeted drugs and immunomodulation.

IMJ July 2025 #OpenAccess Original article: ‘No man's land’ – transition to adulthood for young adults with complex health needs bit.ly/4nITRaC @theracp.bsky.social

IMJ July 2025 #OpenAccess Original Article: Terminal heart failure care for women bit.ly/44UDDDH @theracp.bsky.social

IMJ July 2025 #OpenAccess Original Article: Allogeneic haemopoietic stem cell transplantation for patients with chronic lymphocytic leukaemia bit.ly/3Iltfw0 @theracp.bsky.social

IMJ July (Vol 55, Iss 7) is now online bit.ly/3U2KC7s @theracp.bsky.social @marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social

Want to learn about the prevention of thrombosis in patients with PNH?🩸 Make sure to watch our recent interview from #IPIG2025 with @marrow.bsky.social‬ of @petermaccc.bsky.social‬ in which he discusses this: 🎥 buff.ly/i8Ry0Zr #RareDisease #Hematology #Thrombosis #BloodSky #MedSky

IMJ June 2025 #FreeAccess Editorial: "Two decades at the helm: it only seems like a few weeks". Former Editor-in-Chief (now Emeritus Editor) Jeff Szer looks back at his many years on the IMJ. bit.ly/3FNAg86 @theracp.bsky.social @marrow.bsky.social

IMJ May 2025 #OpenAccess Editor's choice (clinical perspective): Chimeric antigen-T cells and bispecific antibodies bit.ly/3Z3Hrj1 @theracp.bsky.social @marrow.bsky.social

IMJ May (Vol 55, Iss 5) is now online bit.ly/4iVn7XW @theracp.bsky.social @marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social

IMJ April 2025 #FreeAccess Review: Telehealth research trends in Australia bit.ly/3R9ZyPM @marrow.bsky.social @theracp.bsky.social

IMJ April 2025 #FreeAccess Editorial: Climate stewardship in healthcare. Health professionals need to walk the talk in climate change behaviour modelling. bit.ly/3G0TuXB @marrow.bsky.social @theracp.bsky.social

IMJ Apr 2025 #FreeAccess Editor's choice (original article): Cerebral microbleeds in an Australian Memory clinic bit.ly/4cxFzo8 @marrow.bsky.social @theracp.bsky.social

IMJ April (Vol 55, Issue 4) is now online bit.ly/3R38tCq @marrow.bsky.social @theracp.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social

This was a fun episode. Thanks Jenny.

IMJ March 2025 #FreeAccess Brief communication: Non-invasive ventilation in cystic fibrosis bit.ly/3FgHSPF @marrow.bsky.social @theracp.bsky.social

IMJ March 2025 #OpenAccess Brief communication: Bronchiectasis exacerbations among adult Indigenous Australians in the Top End bit.ly/4iHxgaX @marrow.bsky.social @theracp.bsky.social @flindersuniversity.bsky.social @charlesdarwinuni.bsky.socia

IMJ March 2025 #OpenAccess Original article: Return to work in lung transplant recipient bit.ly/43BhQRh @marrow.bsky.social @theracp.bsky.social

IMJ March2025 #FreeAccess Clinical Perspectives: Obesity and the role of incretin agonists bit.ly/3FltVjA @marrow.bsky.social @theracp.bsky.social

IMJ March 2025 #FreeAccess Editorial: A paradigm shift towards a multidisciplinary infective endocarditis management approach bit.ly/43FIlVH bit.ly/4hO4iWD @marrow.bsky.social @theracp.bsky.social

IMJ March 2025 #FreeAccess Review: Excipient-induced allergies in oral medications bit.ly/43CIVDE @marrow.bsky.social @theracp.bsky.social

IMJ March 2025 #OpenAccess Editor's choice (original article): Haematological malignancies during pregnancy bit.ly/3R2gIyB @marrow.bsky.social @theracp.bsky.social

IMJ March (Vol 55, Iss 3) is now online bit.ly/3R38tCq @marrow.bsky.social @theracp.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social

IMJ Feb 2025 #FreeAccess Brief communication: Hydration status prior to right heart catheterisation buff.ly/3EzOY1l @marrow.bsky.social @theracp.bsky.social

IMJ Feb 2025 #FreeAccess Original article: Neoadjuvant chemotherapy in breast cancer buff.ly/3D39OFV @marrow.bsky.social @theracp.bsky.social

IMJ Feb 2025 #FreeAccess Original article: Clinical utility of F-DOPA PET in the movement disorder clinic buff.ly/3X001Yb @marrow.bsky.social @theracp.bsky.social

IMJ Feb 2025 #FreeAccess Clinical Perspectives: Chronic pain management buff.ly/42ZUrZM @marrow.bsky.social @theracp.bsky.social

IMJ Feb 2025 #FreeAccess Review: Non-pharmacological management of irritable bowel syndrome buff.ly/4i2sWCQ @marrow.bsky.social @theracp.bsky.social

IMJ Feb 2025 #FreeAccess Has medicinal cannabis found a role in oncology/palliative care? bit.ly/4hO4iWD @marrow.bsky.social @theracp.bsky.social

IMJ February (Vol 55, Issue 2) is now online bit.ly/4aQcnrm @marrow.bsky.social @theracp.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social

IMJ Feb 2025 #FreeAccess Editor's choice (original article): Antifungal stewardship in Australian hospitals bit.ly/4gBVKkB @marrow.bsky.social @theracp.bsky.social @ianjohnwoolley.bsky.social

#tandem25 #bmtsm Minnie: CNIs inhibit Tphex function but when removed may unveil GVHD T cells. PTCy deplete allo reactive/exhausted T cells. In matched or haplo allos the dominating cells after PTCy differ.

#tandem25 #bmtsm Minnie: PTCy enables tumor driven T cell exhaustion. Decoy resistant IL18 (DR18) therapy can stim GVL T cell responses after PTCy.

Dr M Bleakly from @fredhutch.bsky.social delivering a master class on using minor antigens to create anti-leukemia T cells in the context of HSCT @astct.bsky.social #Tandem25 incredible analysis of hematologic restricted targets